Akorn, INC.

pharmaceutical manufacturing

Based in IL

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $20K in lobbying spend across 4 quarterly filings, Akorn, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2023.

$20K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$10K
2023$10K

Issues Lobbied

Taxation

Lobbying Firms

Government Counsel, LLC

Lobbyists

Henry Menn

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation

  • •CARES Act Section 2305(B) refundable credit
  • •CARES Act Section 2305(B) refundable credit.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Health Care Service Corporation, a Mutual Legal Reserve Company (Hcsc)
$52.8M total spend
Horizon Therapeutics USA, INC. (FKA Horizon Pharma USA, INC.)
$33.6M total spend
Advocate Aurora Health, INC.
$16.8M total spend
International Motors, LLC (Formerly Navistar, INC)
$9.7M total spend
Bmo Bank N.a. (FKA Bmo Harris Bank N.a.)
$6.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.